Total Funding
94
94
Total FundingSeries A raised
Growth Score 94 in past quarter
12 pts
Heat Score 94 in past quarter
91 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
11935
MultiValent Biotherapies is a biotechnology company.
Stephen Snowdy: CEO & FounderPast Role: Visioneering, CEO
About the Company
MultiValent Biotherapies is a private biotechnology company developing targeted drug conjugate therapies for cancer.